 |
|
|
| |
Monthly dosing of ARC-520 in chronically hepatitis B virus infected chimpanzees
produces rapid, deep and durable reductions in circulating viral antigens
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Christine Ilse Wooddell1 , Deborah Chavez2 , Jason E. Goetzmann3 , Lena Marja Notvall-Elkey2 , Helen Lee2 , Bernadette Guerra2 , Ryan M Peterson1 , Courtney Nicole Johnson , Julia O Hegge , Robert Gish4 , Stephen Locarnini3 , Christopher R Anzalone1 , Robert E. Lanford2 , David L Lewis 1
1Arrowhead Research Corporation, Madison, WI;
2 Texas Biomedical Research Institute, San Antonio, TX;
3 University of Louisiana, Lafayette, LA;
4 Stanford University Medical Center, San Diego, CA;
5 Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
|
| |
|
|
|
|
|
